Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$295 Mln
P/E Ratio
--
P/B Ratio
10.64
Industry P/E
--
Debt to Equity
0.99
ROE
-1.33 %
ROCE
-57.57 %
Div. Yield
0 %
Book Value
0.87
EPS
-1.37
CFO
$-189.91 Mln
EBITDA
$-172.19 Mln
Net Profit
$-222.97 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Neuronetics (STIM)
| 178.26 | -4.07 | 83.61 | 19.47 | 16.27 | 14.17 | -- |
|
BSE Sensex*
| 2.52 | 3.37 | 6.44 | 8.80 | 12.18 | 20.37 | 11.43 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Neuronetics (STIM)
| -44.22 | -57.79 | 54.04 | -59.86 | 147.44 | -76.80 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,562.04 | 12.43 | 12.69 | |
| 72.80 | 10,050.19 | 97.07 | 2.52 | |
| 299.78 | 11,550.00 | 278.74 | 3.65 | |
| 117.67 | 14,455.82 | 41.45 | 5.44 |
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment... to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Read more
President, CEO & Director
Mr. Keith J. Sullivan
President, CEO & Director
Mr. Keith J. Sullivan
Headquarters
Malvern, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Neuronetics Inc (STIM) stood at $ 141 Mln as on 31-Dec-24
The share price of Neuronetics Inc (STIM) is $4.48 (NASDAQ) as of 25-Apr-2025 16:19 EDT. Neuronetics Inc (STIM) has given a return of 16.27% in the last 3 years.
Neuronetics Inc (STIM) has a market capitalisation of $ 295 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Neuronetics Inc (STIM) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Neuronetics Inc (STIM) and enter the required number of quantities and click on buy to purchase the shares of Neuronetics Inc (STIM).
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
The CEO & director of Mr. Keith J. Sullivan. is Neuronetics Inc (STIM), and CFO & Sr. VP is Mr. Keith J. Sullivan.
There is no promoter pledging in Neuronetics Inc (STIM).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,126
|
|
|
1,078
|
|
|
1,054
|
|
|
964
|
| Neuronetics Inc. (STIM) | Ratios |
|---|---|
|
Return on equity(%)
|
-141.23
|
|
Operating margin(%)
|
-49.73
|
|
Net Margin(%)
|
-58.36
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Neuronetics Inc (STIM) was $0 Mln.
$0.24
(
